Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Part of paid clinical trials in Storrs, Connecticut.

Sponsor
University of Connecticut
Study ID
NCT05700916
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Milk Polar Lipid-Rich Dairy Powder — DRUG
    Effects of the addition of 6.5 g of milk polar lipids to dairy powder.
  • Dairy Powder — DIETARY_SUPPLEMENT
    Effects of dairy control powder

Study Details

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Key Dates

Start date
Oct 20, 2023
Status verified
Dec 2025
Primary completion
May 31, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
130 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: MPL-rich dairy powder
    Daily consumption of 50 g of dairy powder containing 6.5 g MPL for 8 weeks.
  • Placebo Comparator: Control dairy powder
    Daily consumption of 50 g of dairy powder containing \<0.1 g MPL for 8 weeks

Primary Outcome Measure

Change from Baseline Serum LDL Cholesterol at 8 weeks [ Time Frame: 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of ConnecticutStorrsConnecticut06269
Christopher Blesso, Ph.D.
[email protected]
Christopher Blesso, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Storrs, CT

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Connecticut· Storrs, CT

Related Studies